← Back to headlines
AstraZeneca Sees GLP-1 Market Beyond Weight Loss
AstraZeneca states that the market for GLP-1 drugs extends beyond just weight loss, indicating potential for these medications in treating other conditions.
15 Aug, 12:25 — 15 Aug, 12:25
Sources
Showing 1 of 1 sources
Related Stories
U.S. FDA Approves Landmark Pancreatic Cancer Drug With Improved Survival Rates
47m ago
Australian Woman Gives Birth to Twins Fathered by Two Different Men
57m ago
North Macedonia Reports New West Nile Virus Fatality Amid Enhanced Surveillance
1h ago
Germany Reports Record 15,800 Heat-Related Deaths This Summer
2h ago